SRDAN VERSTOVSEK to Anemia, Refractory, with Excess of Blasts
This is a "connection" page, showing publications SRDAN VERSTOVSEK has written about Anemia, Refractory, with Excess of Blasts.
Connection Strength
0.123
-
Empirical examination of the neutrophil criterion (>1500 microl(-1)) currently needed to declare CR in AML. Leuk Res. 2003 Jun; 27(6):475-9.
Score: 0.055
-
Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes. Cancer. 2003 Mar 15; 97(6):1481-7.
Score: 0.054
-
Effect of circulating blasts at time of complete remission on subsequent relapse-free survival time in newly diagnosed AML. Blood. 2003 Nov 01; 102(9):3097-9.
Score: 0.014